INTRODUCTION
Bacteria and the viruses that infect them (phages) are engaged in an ancient evolutionary arms race, which has resulted in the emergence of a diversity of CRISPR-Cas (and CRISPR-associated genes) adaptive immune systems (Koonin et al., 2017) . CRISPR-Cas immunity is powered by the acquisition of small fragments of phage genomes into the bacterial CRISPR array, the subsequent transcription and processing of these arrays to generate small CRISPR RNAs, and the RNA-guided destruction of the phage genome (Barrangou et al., 2007; Brouns et al., 2008; Garneau et al., 2010; Levy et al., 2015) . The destruction of foreign DNA by CRISPR-Cas has been shown to prevent the acquisition of plasmids, DNA from the environment, phage lytic replication, and prophage integration (Barrangou et al., 2007; Bikard et al., 2012; Cady et al., 2012; Edgar and Qimron, 2010; Garneau et al., 2010; Marraffini and Sontheimer, 2008) . In bacterial populations, these systems provide a fitness advantage to their host microbe when phages are present in the environment (van Houte et al., 2016; Westra et al., 2015) .
To combat the potent action of RNA-guided CRISPR-Cas nucleases, phages have developed inhibitor proteins called antiCRISPRs (Acrs). Acr proteins have been discovered in phages, prophages, mobile islands, and core genomes across many distinct bacteria and archaea (Borges et al., 2017; He et al., 2018; Pawluk et al., 2018) . Specific Acr proteins that inhibit type I-F, I-E, and I-D CRISPR-Cas3 systems have been identified (Bondy-Denomy et al., 2013; He et al., 2018; Pawluk et al., 2014 Pawluk et al., , 2016b , as well as proteins that inhibit type II-A and II-C CRISPRCas9 systems (Hynes et al., 2017; Pawluk et al., 2016a; Rauch et al., 2017) . Phylogenetic studies indicate that these proteins are likely ubiquitous in coevolving populations of bacteria and phages (Pawluk et al., 2018) and provide a significant replicative advantage to phages in the presence of CRISPR-Cas immunity (van Houte et al., 2016) .
Anti-CRISPRs were first identified in phages that neutralize the Pseudomonas aeruginosa type I-F system (anti-CRISPR type I-F, AcrIF1-5) (Bondy-Denomy et al., 2013) , and five more I-F anti-CRISPRs (AcrIF6-10) were subsequently identified in various mobile genetic elements (Pawluk et al., 2016b) . The I-F Csy surveillance complex (also called I-F Cascade) is comprised of an unequal stoichiometry of four proteins (Csy1-4) that assemble with a 60 nt CRISPR RNA (crRNA) guide Guo et al., 2017; Haurwitz et al., 2010; Peng et al., 2017; Przybilski et al., 2011; Richter et al., 2012; Wiedenheft et al., 2011) . The Csy complex locates and binds foreign dsDNA targets complementary to the crRNA, then recruits a trans-acting nuclease/helicase protein called Cas2/3 to degrade the target Wang et al., 2016a Wang et al., , 2016b . Anti-CRISPR proteins function by interacting directly with the Csy complex and inhibiting DNA binding or bind to Cas2/3 and prevent nuclease-mediated degradation (BondyDenomy et al., 2015) . The structures of type I-F Acr proteins AcrIF1, AcrIF2, AcrIF3, and AcrIF10 have been solved in complex with their target proteins, revealing mechanistically distinct inhibitors that bind tightly to their targets Guo et al., 2017; Maxwell et al., 2016; Peng et al., 2017; Wang et al., 2016a Wang et al., , 2016b . Together with the recent identification and characterization of proteins that inhibit Cas9, all characterized Acr proteins block phage DNA binding or cleavage (Dong et al., 2017; Harrington et al., 2017; Pawluk et al., 2016a; Rauch et al., 2017; Shin et al., 2017; Yang and Patel, 2017) .
All AcrIF proteins are robust inhibitors of CRISPR-Cas activity when expressed from high copy plasmids prior to phage challenge, however, this method of CRISPR-inactivation is not reflective of anti-CRISPR deployment by phages in nature. When phage DNA cleavage has been assessed in vivo, it occurs in as little as 2 min (Garneau et al., 2010) , suggesting that phage genome degradation may outpace de novo Acr synthesis and function. We therefore hypothesized that successful inhibition of CRISPR-Cas immunity by Acr proteins during phage infection would be challenging, as all components of the P. aeruginosa immune system are expressed prior to phage infection (BondyDenomy et al., 2013; Cady et al., 2012) .
Here, we demonstrate that complete CRISPR-Cas inactivation by a phage-produced Acr protein is challenging, and the concentration of Acr proteins required to inactivate CRISPR-Cas is contributed by multiple phage genomes. While initial phage infections fail due to rapid genome degradation by the CRISPRCas system, Acr deposition prior to phage destruction causes cellular immunosuppression. If the cell is re-infected, Acr proteins from the initial phage infection enhance the likelihood of subsequent phage replication. We propose that pathogens can contribute to the ''remodeling'' of their host cell via rapid protein production, even if the initial infecting genomes are cleared, opening the door for their clones.
RESULTS

Anti-CRISPR Proteins Are Imperfect CRISPR-Cas Inhibitors
We utilized the diversity of acr genes encoded by phages infecting P. aeruginosa to determine the mechanism of CRISPR-Cas neutralization during infection. Five natural phages, each encoding a single acrIF gene, were selected to represent acrIF1-IF4 and acrIF7 (acrIF5 does not exist as the sole acrIF gene on any phage, acrIF6, F8-F10 are not encoded by this phage family). Three of the five phages exhibited reduced efficiency of plaquing (EOP) on P. aeruginosa strain PA14, which possesses a naturally active type I-F CRISPR-Cas system with 1 or 2 spacers targeting these phages ( Figure 1A , WT:pEmpty normalized to plaquing on PA14 with 0 targeting spacers, 0sp). Overexpression of a targeting crRNA (WT:pSp1) exacerbated anti-CRISPR inefficiency, limiting the replication of all phages by at least one order of magnitude. This suggests that Acr proteins are unable to fully protect their associated phage genome.
To assess anti-CRISPR strength directly, an isogenic phage panel was generated by replacing the acrIE3 gene in the anti-CRISPR locus of phage DMS3m with single acrIF genes F1-F7 (DMS3m acrIF1 -DMS3m acrIF7 ). acrIF1-F5 and acrIF7 are all encoded by DMS3m-like phages in a syntenic anti-CRISPR locus, while acrIF6 was discovered in a distinct type of P. aeruginosa phage. Wild-type (WT) PA14 (1 spacer targeting DMS3m, ''1sp'') and a PA14 derivative that acquired 4 more spacers against DMS3m through laboratory evolution (''5sp'') were challenged with this panel of recombinant phages. For phages encoding acrIF1, F2, F3, F6, or F7, >90% of phage in the population failed to replicate (EOP = 10 À1 ) when faced with 5 targeting spacers ( Figure 1B ). acrIF4 and acrIF5 were very weak, with 99.0%-99.99% of phages failing to replicate, depending on the CRISPR spacer content. Phages must rely on acrIF genes when infecting the 5sp strain, as the acrIE3-encoding phage is unable to escape CRISPR targeting via protospacer mutation alone. We conclude that phages encoding anti-CRISPRs remain sensitive to CRISPR-Cas immunity, suggesting that anti-CRISPR deployment and action is an imperfect process. The observations above identified groups of ''strong'' and ''weak'' Acr proteins. We selected one representative from each group for downstream experiments, and a third Acr that does not target the I-F CRISPR system (i.e., AcrIE3), as a negative control. AcrIF1 was selected as a model strong inhibitor, as its mechanism and binding affinity are known (Csy complex binding, K D = 3 3 10 À11 M) (Bondy-Denomy et al., 2015; Chowdhury et al., 2017) . In contrast, AcrIF4 is a weak inhibitor that also binds the Csy complex (Bondy-Denomy et al., 2015) , but with a significantly slower on-rate and faster off-rate compared to AcrIF1 ( Figures 1C and S1 ).
Lytic Replication Requires a Critical Acr Protein Concentration
We next assessed the survival of bacterial populations when infected with phages that rely on apparently imperfect Acr proteins for survival. To assay the lytic cycle only, phages were prevented from entering lysogeny by knocking out the C repressor gene (gp1) in DMS3m acrIF1 , DMS3m acrIF4 , and DMS3m acrIE3 . The virulent (vir) phages were used to infect the 5sp strain in liquid culture, and bacterial growth was measured.
Given that AcrIF4 has a K D for its binding partner that is >4 orders of magnitude weaker than AcrIF1 for its binding partner, we reasoned that a higher concentration of phages encoding AcrIF4 may be required to inactivate CRISPR-Cas function. In the presence of CRISPR-Cas immunity, bacterial death only occurred at MOI (input plaque forming units per colony forming unit) greater than 0.02 (R10 5 PFU) for acrIF1 ( Figure 2A ) and greater than an MOI of 2.0 (R10 7 PFU) for acrIF4
( Figure 2B ). Phage replication observed here was due to Acr function, and not a result of phage escape mutations, as output phages remained as sensitive to CRISPR-Cas immunity as the input phage population ( Figures S2A-S2C) . Furthermore, the phage encoding acrIE3 had no impact on bacterial survival when faced with CRISPR immunity ( Figure 2C ), while in the absence of CRISPR, phages at all concentrations cleared bacterial cultures ( Figures 2D-2F ). These data demonstrate that Acr-mediated CRISPR-Cas inactivation requires a critical phage concentration that is inversely proportional to Acr strength. We hypothesized that the phage concentration dependence that dictates Acr success is achieved by the contribution of Acr proteins from multiple phage genomes in a single cell, which is not achieved at low MOIs. To this end, we rendered a subset of phages in the population non-replicative Acr donors to test if Acr donation alone is sufficient to rescue a failing (i.e., low MOI) infection. The C repressor gene (gp1) and surrounding immunity region from a DMS3m-like phage (JBD30) was introduced into DMS3m phages, generating a hybrid phage. The replication of the hybrid phage could be specifically prevented by overexpression of the JBD30 C repressor (gp1, Figure S3A ), a protein that does not interfere with DMS3m phage with wild-type immunity regions ( Figure S3B ). This enabled the mixing of two independent phage populations: a sacrificial Acr ''donor'' that cannot replicate and a wild-type (replication competent) Acr ''acceptor. '' In the presence of donor phages encoding AcrIF1 (10 6 PFU, MOI = 0.2), we observed a striking contribution to CRISPR-Cas neutralization, despite the inability of this phage to replicate (Figure S3C) . The acceptor phages DMS3m acrIF1 ( Figure 2G ) and DMS3m acrIF4 ( Figure 2H ) replicated robustly from input MOIs that are unsuccessful in the absence of an AcrIF1 donor phage (Figures 2G and 2H, see ''IE3'' and ''buffer'') . The presence of AcrIF1 donor phages had a mildly protective effect on the DMS3m acrIE3 acceptor phage ( Figure 2I ), although it was not able to reach high titers. Notably, the acceptor phage output from these experiments remain as sensitive to CRISPR-Cas targeting by the 5sp host as the original input phages, demonstrating escape mutations do not arise under these conditions ( Figures S2D-S2G ). Additionally, any potential lysogens formed by the donor phage in this experiment would not have amplified the replicating phage, as these lysogens are resistant to superinfection ( Figure S3D ). These data demonstrate that the determinant of phage replicative success is the concentration of Acr proteins reached in single cells, which is achievable by Acr production from independent phage genomes ( Figure 2J ).
Lysogeny Requires Acr Proteins Contributed by Transient Intracellular Genomes
All phages encoding Acr proteins that infect P. aeruginosa are naturally temperate and can form lysogens by integrating into the bacterial genome. We therefore measured the impact of CRISPR and Acr proteins on lysogeny establishment during a single round of infection. While previous experiments examined cumulative phage replication in the lytic cycle over many hours, assaying lysogen formation over a short time frame is ideal for understanding the initial events that determine phage genome survival or cleavage. Additionally, lysogeny provides a direct readout for phage genome survival (i.e., a cell with an integrated prophage), while in lytic replication, phage survival leads to a dead cell that cannot be recovered. For these experiments, we selected the weak AcrIF4 protein as it provided the largest dynamic range of inefficiency in a single round of infection. We generated derivatives of DMS3m acrIF4 and DMS3m acrIE3 marked with a gentamicin resistance cassette at the end of the genome, replacing a nonessential gene, gp52. This allowed the independent titration of two distinct replication-competent phage populations and the selection and analysis of stable lysogens after the experiment. These phages were used to infect DCRISPR cells (0sp) for a time span less than a single round of infection (50 min, data not shown), and the number of gentamicin resistant lysogens was assessed. In the absence of CRISPR selection, a linear increase in the number of lysogens with increasing MOI was observed, over $4 orders of magnitude (Figures 3A and 3B, circles) . In the presence of spacers targeting DMS3m (5sp), CRISPR immunity reduced the number of lysogen forming units (LFUs) for the weak acr phage DMS3m acrIF4 (Figure 3A, triangles) . DMS3m acrIF4 demonstrated concentration dependence for successful lysogeny, with efficiency of lysogeny (EOL) values below or at the limit of detection for lower MOIs, increasing to EOL = 0.01 at higher MOIs ( Figure 3C ). Phage DMS3m acrIE3 formed no lysogens at all input concentrations tested, demonstrating that Acr-mediated immune suppression is required to establish lysogeny ( Figures 3B and 3D) .
We hypothesized that phage concentration dependence for CRISPR neutralization during lysogeny could also be explained by phage cooperation and that below-threshold concentrations of DMS3m acrIF4 gp52::gent could be rescued by the addition of wild-type (replication competent) Acr donor phages in trans. To test this hypothesis, we infected the 5sp strain with a mixture of 10 3 LFU marked acceptor phage and 10 7 PFU of unmarked Acr donor phages and measured the EOL of the acceptor phage. The EOL of the acceptor phage DMS3m acrIF4 gp52::gent increased by 2 orders of magnitude with Acr donor phage DMS3m acrIF1 and by 1 order of magnitude with the DMS3m acrIF4 donor phage (Figure 3E ). The addition of Acr donor phages DMS3m acrIE3 , or an escaper phage DMS3m acrIE3 * had no effect on the EOL of the acceptor phage, demonstrating that the donor phage must be an Acr-producer. A marked acceptor phage lacking an acrIF gene (DMS3m acrIE3 gp52::gent ) only established rare lysogens in the presence of the AcrIF1 donor phage ( Figure 3F ). To determine the specific mechanism of anti-CRISPR donation leading to survival of the acceptor phages, we used the resulting lysogens as a genetic record of infection success for both the marked acceptor phage and the unmarked donor phage ( Figure 3G ). This family of Mu-like phages integrates randomly into the host genome, allowing for the formation of strains with multiple prophages . We assayed the lysogens resulting from the experiment described above ( Figures 3E and 3F ) for the presence of the donor prophage genome in addition to the acceptor prophage. All resulting DMS3m acrIF4 gp52::gent lysogens (n = 48) possessed only the marked acceptor prophage, with none possessing the Acr donor prophage ( Figures S4A and S4B) . Furthermore, the DMS3m acrIF4 gp52::gent acceptor phages induced from the lysogens that formed only in the presence of Acr donor phages remained sensitive to CRISPR-Cas targeting, indicating these lysogens did not arise due to phage protospacer mutation ( Figure S4B ). Double lysogens only emerged when the marked acrIE3 phage was used as an acceptor phage, which would be incapable of maintaining lysogeny alone due to CRISPR-Cas self-targeting ( Figure 3F ). These results demonstrate that the transient presence (i.e., no lysogeny) of an Acr donor phage genome in a cell was sufficient to generate enough Acr protein to protect the marked acceptor phage, leading to the establishment of lysogens that would not exist if not for the Acr donor ( Figure 3E , compare ''Buffer'' to ''IF1''). Collectively, these data demonstrate that the production of Acr proteins from a phage genome prior to its cleavage generates an immunosuppressed cell that can be successfully parasitized by another phage upon re-or co-infection(s).
Cas9 Inhibitors Require Bacteriophage Cooperation
The intrinsic inefficiency of stoichiometric inhibitors is likely due to the requirement for the rapid synthesis of a high concentration of inhibitors before phage genome cleavage. To determine whether this model generally applies to other stoichiometric inhibitors of bacterial immunity, we engineered a P. aeruginosa strain to express the Cas9 protein from Streptococcus pyogenes (SpyCas9) and a DMS3m phage to express a previously identified Cas9 inhibitor, AcrIIA4 (Dong et al., 2017; Rauch et al., 2017) . With this entirely heterologous system, we again observed inefficiency for a phage relying on an Acr protein. Spot-titration of phage lysates on a strain expressing a single guide RNA (sgRNA) targeting DMS3m decreased the titer of DMS3m acrIE3 by >3 orders of magnitude, while DMS3m acrIIA4 was protected ( Figure 4A ). However, EOP quantification again revealed that relying on an Acr protein for replication is imperfect, with an EOP = 0.4 ( Figure 4B ). In lytic replication infection experiments, DMS3m acrIIA4 displayed concentration-dependent bacterial lysis in the presence of CRISPR targeting ( Figure 4C ), while DMS3m acrIE3 did not affect bacterial growth ( Figure 4D ). The replication of DMS3m acrIIA4 was not due to protospacer mutation leading to phage escape because the output phage population displayed the same EOP as the input (Figures S2H and S2I ). In the absence of CRISPRCas targeting, however, both phages killed their hosts at all phage concentrations tested ( Figures 4E and 4F ).
To determine whether this concentration dependence for Cas9 inhibition was also a result of insufficient intracellular Acr dose, a non-replicative hybrid DMS3m acrIIA4 phage was generated and used as an Acr donor during infection. Indeed, increased delivery of AcrIIA4 to cells enhanced replication of the wild-type DMS3m acrIIA4 acceptor phage by 4 orders of magnitude ( Figure 4G ), demonstrating phage cooperation neutralizes CRISPR-Cas9. AcrIIA4 donation was able to slightly rescue an acceptor phage without a II-A Acr, DMS3m acrIE3 (Figure 4H) , however, this phage was unable to replicate to high titers. Furthermore, the effect of an AcrIIA4 donor rescuing either DMS3m acrIIA4 or DMS3m acrIE3 was not due to mutational escape of the acceptor phage ( Figures S2J-S2L ), demonstrating these phages had survived solely due to the immunosuppressive effect of AcrIIA4 donation ( Figure 4I ). Collectively, these data demonstrate that phage-phage cooperation via cellular immunosuppression is a broadly useful strategy to overcome bacterial immunity.
DISCUSSION
Here, we demonstrate that the necessary intracellular concentration of an anti-CRISPR protein to achieve inactivation of CRISPR-Cas immunity depends on the relative strengths of both the inhibitor and CRISPR immunity, which dictates the number of infecting viruses required in the population. We conclude that a single cell can become immunosuppressed by Acr protein contributions from independent infection events. In the absence of viral replication, these infection events serve to contribute to the inactivation of cellular immunity, thus enhancing the probability of successful infection events in the future. We expect that cooperation of this sort is necessary when the immune process acts rapidly and irreversibly on the infecting viral genome, as CRISPR-Cas immunity does. Anti-CRISPR deployment and successful CRISPR-Cas inactivation requires a critical concentration of phage in the population to allow replication in the lytic or lysogenic cycle. We used three distinct genetic strategies to monitor phage-phage cooperation within an otherwise clonal population, allowing the independent titration and tracking of isogenic phages: (1) non-replicative Acr donor phages, (2) marked and unmarked phages to follow the fate of only one phage, and (3) the prophage status of lysogens, as a genetic record of phage success. In the presence of nonreplicative Acr donor phages, we observed the successful lytic amplification of a low-dose of wild-type phages, otherwise destined for replication failure ( Figures 2G and 2H ). This provided an explanation for the observed phage inefficiencies during plaque assays ( Figures 1A and 1B) and population concentration thresholds in liquid infections (Figures 2A and 2B) . Next, the acquisition of a marked prophage was monitored in the presence of wild-type Acr-donor phages. AcrIF proteins provided in trans caused cellular immunosuppression, enabling the formation of lysogens that were not established in their absence ( Figures 3E  and 3F ). The presence of only a single, marked prophage in the bacterial genome demonstrates that the donor phage neither entered the lytic cycle (this would kill the cell), nor lysogenized (prophage would be integrated), but had been present in the cell transiently.
The key result here is the observation that phages can remodel their host cell, even in the absence of a replicating or integrated genome. It has long been known that integrated prophages modulate host phenotypes via gene expression, including superinfection exclusion, toxin production, and the production of Acr proteins (Bondy-Denomy et al., 2013 Bondy-Denomy and Davidson, 2014; Waldor and Mekalanos, 1996; Weigle and Delbruck, 1951) . Furthermore, the Imm protein produced by the lytic phage T4 prevents other phages in the environment from infecting the cell that one phage is currently replicating within (Lu and Henning, 1989) . This has been attributed to preventing sequential infections and the disruption of the carefully timed phage replication cycle. In contrast to these examples, Figure S2 .
we propose a new model of phage-induced host remodeling, whereby a transient, unsuccessful infection produces proteins that inactivate defense, enabling future infections. Consistent with our observations of viral cooperation, beneficial virus-virus interactions in both eukaryotic and prokaryotic systems have been previously observed. Broadly, these phenomena can be separated into 2 categories: (1) cooperative interactions between distinct viral genotypes, and (2) group behaviors manifested in clonal viral populations. In the first category, similar to Acr proteins functioning as a public good, genetically distinct viruses can share protein products during coinfection (Xue et al., 2016) , even bypassing deleterious mutations in cis via functional complementation in trans (Aguilera et al., 2017; Cicin-Sain et al., 2005; Vignuzzi et al., 2006) . Additionally, the direct exchange of viral genetic material can also increase viral fitness. The mosaic nature of phage genomes (Botstein, 1980; Hatfull and Hendrix, 2011; Hendrix et al., 1999) and the high abundance of chimeric viruses in nature highlights the importance of coinfection and genetic exchange in viral evolution (Diemer and Stedman, 2012; Krupovic et al., 2015; Roux et al., 2013) . In fact, CRISPR-targeted phages can evade CRISPR-Cas immunity via homologous recombination with genetically distinct phages, disrupting protospacers (Andersson and Banfield, 2008; Paez-Espino et al., 2015) . In the second category, group behaviors manifesting in clonal populations of virus is less frequently reported, likely because they leave no genetic signature. However, the lambda lytic/lysogeny switch is a famous example of phage group behavior: during lambda phage co-infection, high concentrations of the CII protein product derived from multiple infecting clones drives the cooperative decision to enter lysogeny (Kourilsky and Knapp, 1974; Trinh et al., 2017; Zeng et al., 2010) . In more recent literature, the discovery of the widespread arbitrium system as the first phage-phage communication mechanism demonstrates the potential of phages to act as a group and manifest cooperative behaviors (Erez et al., 2017) . The immunosuppressive mechanism of anti-CRISPR function further exemplifies cooperation within clonal populations of phages, which may occur more often than was previously appreciated. The distinct aspect here is the altruistic nature of immunosuppression: to neutralize CRISPR-Cas immunity, many infections must fail such that a few can succeed. To our knowledge this is the first documented example of true viral altruism, which is evolutionary beneficial only through kin selection.
A distinct, but notable observation from this work is that not all Acr proteins operate at equivalent strengths. However, encoding even a weak inhibitor (e.g., AcrIF4) still provides a significant advantage to the phage, compared to lacking them entirely (Figure 1B) . AcrIF4 binds the Csy complex with an affinity that is orders of magnitude weaker ( Figure 1C ) than AcrIF1 , which we consider to be representative of other strong Acr proteins (AcrIF2, F3, F6, F7 ), based on EOP data. Going forward, we speculate that the strongest Acr proteins would be enzymatic in nature, allowing rapid and efficient inactivation of CRISPR complexes in a sub-stoichiometric manner, although no such Acr mechanism has been discovered. While not an enzyme, the recent demonstration of the AcrIIC3 protein inactivating two Cas9 proteins at the same time would likely be a more efficient path toward CRISPR neutralization (Harrington et al., 2017) . It is also interesting to consider individual bacterial strains that encode multiple CRIPSR-Cas system subtypes (Carte et al., 2014; Patterson et al., 2016; van Belkum et al., 2015) , all which must be neutralized in order for a targeted phage to replicate. A dual-activity inhibitor is likely at a specific disadvantage in this scenario, as one protein would be tasked with inhibiting Cas proteins produced by two different systems. This may in part explain why DMS3m-like Pseudomonas phages often encode dedicated type I-E and type I-F Acrs in the same Acr locus (Bondy-Denomy et al., 2013; Pawluk et al., 2014) , instead of employing dual I-F and I-E inhibitors such as AcrIF6 (Pawluk et al., 2016b) . Although encoding multiple Acrs comes with the burden of more genetic cargo in a phage's genome, this strategy could be advantageous on a biochemical level when infecting a bacterial strain with multiple CRISPR-Cas subtypes.
The challenge of neutralizing a pre-expressed CRISPR-Cas system likely explains why stoichiometric inhibitors like Acr proteins are imperfect, and phages relying on them are partially targeted by CRISPR. The sacrificial, population-level aspect of CRISPR inhibition is reminiscent of the manifestations of CRISPR adaptation in populations of bacterial cells. The majority of infected naive host cells die, before a clone with a new spacer emerges (Barrangou et al., 2007; Hynes et al., 2014) . In the case of anti-immunity, many phages die in order to inhibit CRISPR on a single cell level and this must happen at a sufficient frequency within a community for phage to prevail. We suspect that this mechanism of cellular immunosuppression and inter-parasite cooperation may have parallels in other host-pathogen interactions, where concentration dependence manifests at predictable levels due the strengths of immune and anti-immune processes.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Microbes
Pseudomonas aeruginosa strains (UCBPP-PA14 and PAO1) and Escherichia coli strains (DH5a, for plasmid maintenance) were cultured on lysogeny broth (LB) agar or liquid media at 37 C. LB was supplemented with gentamicin (50 mg/mL for P. aeruginosa, 30 mg/mL for E. coli) to maintain the pHERD30T plasmid or carbenicillin (250 mg/mL for P. aeruginosa, 100 mg/mL for E. coli) to maintain pHERD20T or pMMB67HE. To maintain pHERD30T and pMMB67HE in the same strain of P. aeruginosa, double selection of 30 mg/mL gentamicin and 100 mg/mL carbenicillin was employed. In all P. aeruginosa experiments, expression from pHERD20/ 30T was induced with 0.1% arabinose and expression from pMMB67HE was induced with 1mM Isopropyl b-D-1-thiogalactopyranoside (IPTG). Escherichia coli strains BL21 (DE3) were grown in LB broth supplemented with ampicillin (100 mg/mL) to maintain pAcrIF4, or with ampicillin (100 mg/mL) and kanamycin (50 mg/mL) to maintain pCsy and pCRISPR together.
Phages
Pseudomonas aeruginosa DMS3m-like phages (JBD30, MP29, JBD88a, JBD24, LPB1, DMS3m and DMS3m derivatives) were amplified on PA14 DCRISPR or PAO1 and stored in SM buffer at 4 C.
METHOD DETAILS
Construction of PA14 crRNA overexpression strains PA14 CRISPR2 spacer-17 or CRISPR2 spacer-20 sequences flanked by PA14 Type I-F direct repeats were ordered as complementary ssDNA oligos (IDT), annealed, and ligated into the NcoI/HindIII site in pHERD30T to make pAB02 and pAB03, respectively. These constructs were transformed into PA14 WT, and expression induced with 0.1% arabinose.
Construction of PAO1::SpyCas9 expression strain SpyCas9 expressed from the P LAC promoter of pUC18T-mini-Tn7T-Gm (pBAO95) was integrated into the P. aeruginosa strain PAO1 chromosome by electroporation and Flp-mediated marker excision as previously described (Choi and Schweizer, 2006) . To generate the heterologous Type II-A PAO1 strain the PAO1-attTn7::pUC18T-miniTn7T-P LAC -SpyCas9 strain was transformed with pMMB67HE-P LAC -sgRNA (pBAO72) by electroporation. In all experiments with this strain, SpyCas9 and the sgRNA were induced with 1mM IPTG.
Construction of recombinant DMS3m acr phages DMS3m acrIF1 was generated previously (Bondy-Denomy et al., 2013) by infecting cells containing a recombination plasmid bearing JBD30 genes 34-38 (the anti-CRISPR locus with large flanking regions). JBD30 naturally carries acrIF1 and has high genetic similarity to DMS3m acrIE3 , permitting for the selection of recombinant DMS3m phages that acquired acrIF1. To generate the extended panel of DMS3m acr phages in this work, recombination cassettes were generated with regions from up and downstream the anti-CRISPR gene from JBD30 and these fragments were assembled to flank the acr gene of interest on pHERD20T or pHERD30T (see Table  S1 for acr gene sources, Table S2 for recombination plasmids) using Gibson assembly methods. In the case of AcrIF5, AcrIF6, and AcrIIA4 recombination cassettes, a ribosomal binding site was introduced between the acr and the downstream gene aca1 to ensure proper expression of the aca1 gene. Recombinant phages were generated by infecting cells bearing these recombination substrates. DMS3m acr phages were screened for their ability to resist CRISPR targeting, and the insertion of the anti-CRISPR gene was confirmed by PCR. Virulent derivatives of DMS3m acr phages were constructed by deleting gp1 (C repressor) using materials and methods previously generated (Cady et al., 2012) .
Construction of DMS3m acr gp52::gent phages A recombination substrate (pAB45) with a gentamicin resistance cassette flanked by homology arms matching the DMS3m genome up and downstream of gp52 (450 bp and 260 bp, respectively) was assembled into pHERD20T using Gibson assembly. This recombination cassette was transformed into PA14 DCRISPR lysogenized with either DMS3m acrIE3 or DMS3m acrIF4 .These transformed lysogens were grown under gentamicin selection for 16 hours, then sub-cultured 1:100 into LB with gentamicin and 0.2 mg/mL mitomycin C to induce the DMS3m acr prophage. Supernatants were harvested after 24 hours of induction, and used to infect PA14 DCRISPR in liquid culture for 24 hours. These cells were then plated on gentamicin plates to select for cells that had acquired a prophage bearing the gentamicin resistance cassette, and gentamicin resistant lysogens were then re-induced with 0.2 mg/mL mitomycin C to recover the recombinant phage.
Construction of DMS3m acr gp1-JBD30 Hybrid acr phages DMS3m acrIE3 and JBD30 acrIE3 were used to co-infect PA14 DCRISPR and the infected cells were mixed with molten top agar and poured onto solid plates. After 24 hours of growth at 30 C, the phages were harvested by flooding the plate with SM buffer and collecting and clarifying the supernatant. Phages were then used to infect PA14 DCRISPR expressing the DMS3m C repressor from pHERD30T (pAB80), and the infections were mixed with molten top agar and poured onto solid plates. After 24 hours of growth at 30 C, individual plaques with DMS3m morphology were picked, purified 3x by passage in PA14 DCRISPR and screened as shown in Figure S3B . The acrIF1 gene was then knocked in to this hybrid phage using methods described above to generate DMS3m acrIF1 gp1-JBD30 .
Plaque forming unit quantification
Phage plaque forming units (PFU) were quantified by mixing 10 ml of phage with 150 ml of an overnight culture of host bacteria. The infection mixture was incubated at 37 C for 10 minutes to promote phage adsorption, then mixed with 3 mL molten top agar and spread on an LB agar plate supplemented with 10 mM MgSO 4 . After 16 hours of growth 30 C, PFUs were quantified.
Phage titering A bacterial lawn was generated by spreading 3 mL of top agar seeded with 150 ml of host bacteria on a LB agar plate supplemented with 10 mM MgSO 4 . 3 ml of phage serially diluted in SM buffer was then spotted onto the lawn, and incubated at 30 C for 16 hours.
Liquid culture phage infections A P. aeruginosa overnight culture was diluted 1:100 in LB supplemented with 10 mM MgSO4, required antibiotics and inducer. 140 ml of diluted bacteria were then infected with 10 ml of phage diluted in SM buffer in a 96 well Costar plate. These infections proceeded for 24 hours in a Synergy H1 microplate reader (BioTek, using Gen5 software) at 37 C with continuous shaking. After 24 hours, phage was extracted by treating each sample with chloroform followed by centrifugation at 21,000 x g for 2 minutes.
Prophage acquisition and lysogen analysis Overnight cultures of PA14 were subcultured at 1:100 for $3 hours (OD 600nm = 0.3) in LB supplemented with 10 mM MgSO 4 . 1 mL of cells was infected with 10 ml DMS3m acr gp52::gent and incubated for 50 minutes at 37 C, shaking at 100 rpm. The sample was then treated with a 10% volume of 10X gentamicin, spun down at 8,000xg, and resuspended in 200 ml of LB with 50 mg/mL gentamicin. 100 ml of sample was then plated (after further dilution, if required) on gentamicin selection plates and incubated at 37 C. To analyze the lysogens, the resulting colonies were grown for 16 hours in LB + 10 mM MgSO 4 (no selection), the supernatants harvested, and serial dilutions spotted onto lawns of non-targeting PA14 (0sp) or PA14 with 5 targeting spacers (5sp). Crude genomic DNA for PCR analysis was harvested from the lysogens by boiling 10 ml of culture in 0.02% SDS for 10 minutes.
Lysogen PCR PCR amplification of 2 ml of crude genomic DNA harvested from lysogens was used to screen for the presence of DMS3m-gp52 and the gent cassette using MyTaq (Bioline) polymerase with MyTaq GC buffer under standard conditions.
Csy complex purification
Csy genes and a synthetic CRISPR array were co-expressed on separate vectors (pCsy, pCRISPR) in E. coli BL21 (DE3) cells as previously described . Expression was induced with 0.5 mM Isopropyl b-D-1-thiogalactopyranoside (IPTG) at OD 600 $0.5. Cells were incubated overnight at 16 C, then pelleted by centrifugation (5,000 3 g for 15 min at 4 C), and resuspended in lysis buffer [50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.5, 300 mM potassium chloride, 5% glycerol, 1 mM Tris(2-carboxyethyl) phosphine hydrochloride (TCEP), 1 3 protease inhibitor mixture (Thermo Scientific)]. Pellets were sonicated on ice for 3 3 2.5 min (1 s on, 3 s off), and then the lysate was clarified by centrifugation at 22,000 3 g for 30 min at 4 C. The Csy complex self-assembles in vivo, and the intact complex was affinity-purified over NiNTA Superflow resin (QIAGEN) using 6xhis tags on Cas7f. Protein was eluted with lysis buffer supplemented with 300 mM imidazole and then concentrated (Corning Spin-X concentrators) at 4 C before further purification over a Superdex 200 size-exclusion column (GE Healthcare) in 20 mM HEPES pH 7.5, 100 mM KCl, 5% glycerol, and 1 mM TCEP.
